Targeting SPMS: Effect of teriflunomide treatment on microglial activation in an MS patient cohort at risk of progression. A [11C]PK11195 Brain PET study.
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms TERIPET
- 07 Feb 2018 Status changed from not yet recruiting to recruiting.
- 04 Oct 2017 New trial record